Non-small Sell Lung Cancer (NSCLC)
1 clinical trials · Condition
◉ Watch Non-small Sell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of PDR001 in Patients With Advanced Malignancies (NCT02404441) | Novartis Pharmaceuticals | 2015-04-27 |
Track Non-small Sell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.